Eli Lilly Cuts This autumn Earnings Steering, Expects Round $5.5 Billion Gross sales From Weight Loss/Diabetes Medication, Inventory Tanks
Eli Lilly Cuts This autumn Earnings Steering, Expects Round $5.5 Billion Gross sales From Weight Loss/Diabetes Medication, Inventory Tanks On Tuesday, Eli Lilly and Co (NYSE: LLY) introduced that it expects 2024 full-year